Mylan to Settle EpiPen Overpricing Case for $465 Million – New York Times

New York TimesMylan, the maker of the allergy treatment EpiPen, said Friday that it had reached a $465 million settlement with the Justice Department and other government agencies over questions on whether the company had overcharged Medicaid for the treatment by … and more …read more From:: New York City News By Google News

from WordPress http://ift.tt/2dBsHk3
via IFTTT